Sun, Nov 29, 2015
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Apple & Allergan top list of hedge fund positions

Wednesday, August 27, 2014

Bailey McCann, Opalesque New York:

S&P Capital IQ is out with its quarterly hedge fund tracker, ranking the positions of pure play hedge funds based on reported data including Form 13F. Report data finds that information technology and healthcare stocks saw the largest growth in new hedge fund buying activity during Q2 2014, with Allergan and Apple as the most popular individual stocks.

On a sector basis, IT stocks saw hedge fund flows of $1.45 billion leading the pack for the second quarter in a row. Healthcare was at second most popular, for the top 10 hedge funds with $1.4 billion. Financials down $2.25 billion, with a decrease in American International Group $686 and Crown Castle International $272.

Allergan Inc. was the top new buy among the largest 10 hedge funds with $1.43 billion in new positions, 6 funds holding it; 2 brand new funds bought the company, 2 increasing existing positions and 2 held their stake. The company is being aggressively pursued by Valeant Pharmaceuticals Intl Inc. (VRX) and Pershing Square Capital Management LP for a takeover.

Apple saw the second-highest level of new buying activity among hedge funds with $855 million in new buys in Q2. Last quarter it was the second top buy with $1.95 billion bought, but, also the second top sell with $871 million sold. This quarter, we see no such ambivalence. Also listing the top 100 po......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Other Voices: Hedge fund marketing and the selling cycle[more]

    By Bruce Frumerman. How long is the selling cycle now? That’s a question my financial communications and sales marketing consulting firm has been asked on a regular basis by hedge fund firm owners and sales people, ever since we opened the doors to our firm in 1987 pre-crash. Wa

  2. People - Solus Alternative Asset Management adds chief strategist from BTIG[more]

    From Daniel Greenhaus joined hedge fund manager Solus Alternative Asset Management as managing director and chief strategist. He will work closely with Chris Bondy, Solus’ chief economist, managing director and executive vice president, said Chris Pucillo, CEO and chief investmen

  3. Opalesque Roundtable: Seeding deal terms can be onerous for hedge funds[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Executives from fund of funds firms, family offices, a placement agent, a private equity firm, and an accounting firm gathered in Connecticut last month for the

  4. Opalesque Roundtable: Family offices flock to co-investment[more]

    Bailey McCann, Opalesque New York: Co-investments have been a hot topic for pension funds in recent years, as they try to move away from high fees and improve transparency. But now, family offices are more readily getting into the mix and establishing in-house deal teams, according to the delega

  5. More institutional investors invest in CTAs compared to last year despite dissatisfaction with performance[more]

    Benedicte Gravrand, Opalesque Geneva: "Despite a strong start to 2015 for CTAs in Q1, commodity market conditions have made return generation difficult for fund managers over much of the rest of the year to date," says Preqin’s November